asfotase alfa
asfotase alfa is listed in the FDA National Drug Code directory with 4 NDC codes. Available dosage form: solution.
Drug Details
- Generic Name
- asfotase alfa
- Brand Names
- N/A
- Application Number
- Sponsor
- Patheon Italia S.p.A.
- NDC Codes
- 4
- Dosage Forms
- SOLUTION
- Routes
- N/A
- Active Ingredients
- ASFOTASE ALFA
Indications and Usage
1 INDICATIONS AND USAGE STRENSIQ ® is indicated for the treatment of patients with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP). STRENSIQ is a tissue nonspecific alkaline phosphatase indicated for the treatment of patients with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP). ( 1 )